Coping with Information Loss and the Use of Auxiliary Sources of Data: A Report from the NISS Ingram Olkin Forum Series on Unplanned Clinical Trial Disruptions

06/22/2022
by   Silvia Calderazzo, et al.
0

Clinical trials disruption has always represented a non negligible part of the ending of interventional studies. While the SARS-CoV-2 (COVID-19) pandemic has led to an impressive and unprecedented initiation of clinical research, it has also led to considerable disruption of clinical trials in other disease areas, with around 80 pandemic. In many cases the disrupted trials will not have the planned statistical power necessary to yield interpretable results. This paper describes methods to compensate for the information loss arising from trial disruptions by incorporating additional information available from auxiliary data sources. The methods described include the use of auxiliary data on baseline and early outcome data available from the trial itself and frequentist and Bayesian approaches for the incorporation of information from external data sources. The methods are illustrated by application to the analysis of artificial data based on the Primary care pediatrics Learning Activity Nutrition (PLAN) study, a clinical trial assessing a diet and exercise intervention for overweight children, that was affected by the COVID-19 pandemic. We show how all of the methods proposed lead to an increase in precision relative to use of complete case data only.

READ FULL TEXT

page 1

page 2

page 3

page 4

research
05/28/2020

Clinical trials impacted by the COVID-19 pandemic: Adaptive designs to the rescue?

Very recently the new pathogen severe acute respiratory syndrome coronav...
research
12/19/2022

Towards Assessing Data Bias in Clinical Trials

Algorithms and technologies are essential tools that pervade all aspects...
research
05/31/2023

Reinforced Borrowing Framework: Leveraging Auxiliary Data for Individualized Inference

Increasingly during the past decade, researchers have sought to leverage...
research
07/31/2020

Causal inference methods for small non-randomized studies: Methods and an application in COVID-19

The usual development cycles are too slow for the development of vaccine...
research
05/05/2020

In Silico Trial to test COVID-19 candidate vaccines: a case study with UISS platform

SARS-CoV-2 is a severe respiratory infection that infects humans. Its ou...
research
08/15/2019

A hypothesis test of feasibility for external pilot trials assessing recruitment, follow-up and adherence rates

The power of a large clinical trial can be adversely affected by low rec...

Please sign up or login with your details

Forgot password? Click here to reset